Healthcare provider profile · identity verified

Dipauni S Doshi, M.D.

Internal Medicine · DALLAS, TX · NPI 1831162874

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Levothyroxine Sodium	Levothyroxine Sodium	496	62
Atorvastatin Calcium	Atorvastatin Calcium	431	74
Eliquis	Apixaban	294	30
Donepezil Hcl	Donepezil Hcl	257	33
Potassium Chloride	Potassium Chloride	250	45
Gabapentin	Gabapentin	236	44
Escitalopram Oxalate	Escitalopram Oxalate	234	27
Furosemide	Furosemide	224	38
Lisinopril	Lisinopril	223	36
Amlodipine Besylate	Amlodipine Besylate	215	40
Memantine Hcl	Memantine Hcl	210	28
Trazodone Hcl	Trazodone Hcl	198	34
Tamsulosin Hcl	Tamsulosin Hcl	189	29
Pantoprazole Sodium	Pantoprazole Sodium	165	27
Hydralazine Hcl	Hydralazine Hcl	154	28
Mirtazapine	Mirtazapine	151	29
Clopidogrel	Clopidogrel Bisulfate	132	23
Losartan Potassium	Losartan Potassium	130	18
Oxcarbazepine	Oxcarbazepine	119	11
Carvedilol	Carvedilol	117	23
Lorazepam	Lorazepam	117	22
Metoprolol Succinate	Metoprolol Succinate	114	22
Divalproex Sodium	Divalproex Sodium	110	19
Tramadol Hcl	Tramadol Hcl	105	23
Simvastatin	Simvastatin	98	12
Metoprolol Tartrate	Metoprolol Tartrate	94	20
Alprazolam	Alprazolam	93	12
Omeprazole	Omeprazole	93	18
Levetiracetam	Levetiracetam	92	13
Montelukast Sodium	Montelukast Sodium	91	15
Quetiapine Fumarate	Quetiapine Fumarate	87	suppressed
Sertraline Hcl	Sertraline Hcl	87	17
Baclofen	Baclofen	84	13
Metformin Hcl	Metformin Hcl	79	16
Lamotrigine	Lamotrigine	75	suppressed
Olanzapine	Olanzapine	75	suppressed
Duloxetine Hcl	Duloxetine Hcl	73	11
Pravastatin Sodium	Pravastatin Sodium	72	14
Fluoxetine Hcl	Fluoxetine Hcl	71	suppressed
Warfarin Sodium	Warfarin Sodium	65	suppressed
Paroxetine Hcl	Paroxetine Hcl	62	suppressed
Amiodarone Hcl	Amiodarone Hcl	61	13
Xarelto	Rivaroxaban	61	suppressed
Famotidine	Famotidine	59	suppressed
Finasteride	Finasteride	56	11
Methocarbamol	Methocarbamol	56	19
Memantine Hcl Er	Memantine Hcl	54	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	50	20
Clonazepam	Clonazepam	47	suppressed
Allopurinol	Allopurinol	45	suppressed
Nifedipine Er	Nifedipine	44	11
Risperidone	Risperidone	44	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	43	suppressed
Hydrochlorothiazide	Hydrochlorothiazide	41	suppressed
Linzess	Linaclotide	41	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	40	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	40	suppressed
Alendronate Sodium	Alendronate Sodium	39	suppressed
Latanoprost	Latanoprost	38	suppressed
Ipratropium-Albuterol	Ipratropium/Albuterol Sulfate	37	22
Midodrine Hcl	Midodrine Hcl	36	11
Tizanidine Hcl	Tizanidine Hcl	36	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	35	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	34	12
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	33	suppressed
Buspirone Hcl	Buspirone Hcl	32	suppressed
Primidone	Primidone	31	suppressed
Brimonidine Tartrate	Brimonidine Tartrate	30	suppressed
Propafenone Hcl	Propafenone Hcl	29	suppressed
Bupropion Hcl	Bupropion Hcl	28	suppressed
Digoxin	Digoxin	28	suppressed
Jardiance	Empagliflozin	28	suppressed
Levofloxacin	Levofloxacin	28	21
Rosuvastatin Calcium	Rosuvastatin Calcium	28	suppressed
Fluticasone Propionate	Fluticasone Propionate	27	13
Glipizide	Glipizide	27	suppressed
Insulin Glargine-Yfgn	Insulin Glargine-Yfgn	27	13
Topiramate	Topiramate	27	suppressed
Bumetanide	Bumetanide	26	suppressed
Torsemide	Torsemide	26	suppressed
Ondansetron Hcl	Ondansetron Hcl	25	15
Myrbetriq	Mirabegron	24	suppressed
Dorzolamide-Timolol	Dorzolamide Hcl/Timolol Maleat	22	suppressed
Entresto	Sacubitril/Valsartan	22	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	22	suppressed
Mupirocin	Mupirocin	22	suppressed
Sevelamer Carbonate	Sevelamer Carbonate	22	suppressed
Temazepam	Temazepam	22	suppressed
Folic Acid	Folic Acid	21	suppressed
Novolin R Flexpen	Insulin Regular, Human	21	suppressed
Sucralfate	Sucralfate	21	suppressed
Valproic Acid	Valproic Acid (As Sodium Salt)	21	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	21	suppressed
Acebutolol Hcl	Acebutolol Hcl	20	suppressed
Humalog Kwikpen U-100	Insulin Lispro	20	suppressed
Nystatin	Nystatin	20	suppressed
Pregabalin	Pregabalin	20	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	19	suppressed
Cinacalcet Hcl	Cinacalcet Hcl	18	suppressed
Citalopram Hbr	Citalopram Hydrobromide	18	suppressed
Diltiazem Hcl	Diltiazem Hcl	18	suppressed
Metolazone	Metolazone	18	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	18	13
Admelog Solostar	Insulin Lispro	17	suppressed
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	17	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	17	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	17	suppressed
Lactulose	Lactulose	17	suppressed
Sodium Chloride	0.9 % Sodium Chloride	17	suppressed
Clonidine Hcl	Clonidine Hcl	16	suppressed
Daptomycin	Daptomycin	16	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	16	suppressed
Zonisamide	Zonisamide	16	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	15	suppressed
Ampicillin-Sulbactam	Ampicillin Sod/Sulbactam Sod	15	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	15	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	15	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	15	suppressed
Benztropine Mesylate	Benztropine Mesylate	14	suppressed
Autoshield Duo Pen Needle	Pen Needle,dual Safety,diabetc	13	suppressed
Carbidopa-Levodopa Er	Carbidopa/Levodopa	13	suppressed
Nadolol	Nadolol	13	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	13	suppressed
Valsartan	Valsartan	13	suppressed
Carbamazepine	Carbamazepine	12	suppressed
Ezetimibe	Ezetimibe	12	suppressed
Glatopa	Glatiramer Acetate	12	suppressed
Letrozole	Letrozole	12	suppressed
Phenobarbital	Phenobarbital	12	suppressed
Ropinirole Hcl	Ropinirole Hcl	12	suppressed
Sotalol	Sotalol Hcl	12	suppressed
Bupropion Xl	Bupropion Hcl	11	suppressed
Cefdinir	Cefdinir	11	11
Prednisone	Prednisone	11	suppressed
Promethazine Hcl	Promethazine Hcl	11	suppressed
Trihexyphenidyl Hcl	Trihexyphenidyl Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error